A document published in the Canadian Journal of Cardiology outlines the Canadian Cardiovascular Society’s classification of acute MI.
FDA Panel to Consider Arimoclomol for Rare Genetic Disorder
An FDA advisory committee meeting this week will focus on whether an investigative treatment for an ultra-rare and fatal neurovisceral genetic disorder is truly efficacious.